Skip to content
InsiderLens
Feed
Screener
MCP
Methodology
⌘K
EN
Pricing
Sign in
Feed
Screener
MCP
Methodology
EN
English
Español
Français
Pricing
Sign in
Attovia Therapeutics, Inc. (ATTO) — insider transactions · InsiderLens
/
/
Attovia Therapeutics, Inc.
Attovia Therapeutics, Inc.
ATTO
Insider trading at Attovia Therapeutics, Inc.
No insider transactions on record for Attovia Therapeutics, Inc..
Insiders on record at Attovia Therapeutics, Inc.
Attovia Therapeutics, Inc.
Chief Financial Officer
· Director
Chen Hubert
Chief Medical Officer
Odrowaz Zaneta
Chief Business Officer
Veiby Petter
Chief Scientific Officer
GOLD MITCHELL
Director
Royston Aaron
Director
Smither John W
Director
Topper James N
Director
Walsh Colin
Director
You Angie
Director
Alamar HoldCo, LLC
10% owner
Broad Street Principal Investments, L.L.C.
10% owner
Deep Track Biotechnology Master Fund, Ltd.
10% owner
Deep Track Capital, LP
10% owner
FHMLS XI, L.L.C.
10% owner
FHMLS XI, L.P.
10% owner
Show all 33 insiders on record
Frazier Life Sciences XI, L.P.
10% owner
GOLDMAN SACHS & CO
10% owner
GOLDMAN SACHS ASSET MANAGEMENT, L.P.
10% owner
GOLDMAN SACHS GROUP INC/
10% owner
Green Jeremy
10% owner
KROIN DAVID
10% owner
Redmile Biopharma Investments III, L.P.
10% owner
Redmile Group, LLC
10% owner
SANOFI-AVENTIS
10% owner
venBio Global Strategic Fund IV, L.P.
10% owner
Vida Ventures GP III, L.L.C.
10% owner
Vida Ventures III-A, L.P.
10% owner
Vida Ventures III, L.P.
10% owner
West Street Life Sciences I, L.P.
10% owner
WSLS EMP OFFSHORE INVESTMENTS, L.P.
10% owner
WSLS EMP ONSHORE INVESTMENTS, L.P.
10% owner
WSLS OFFSHORE INVESTMENTS, SLP
10% owner
Home
Companies
Insider transaction history at Attovia Therapeutics, Inc.
Latest
Largest
No transactions on record.
Reset filters